Institutional Ownership Eliem Therapeutics, Inc. (ELYM)
This table provides information about the institutional ownership of Eliem Therapeutics, Inc. (ELYM). We have compiled data on the 76 institutions that hold shares in the stock, with a total of 51 Million shares, which have been reported (via 13F filing form) to have a value of $210 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
226,850
shares
|
$932,353
0.0% of portfolio
|
Q4 2024
Added 190.16%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Feb 14, 2025 Q4 2024 |
175,088
shares
|
$719,611
0.12% of portfolio
|
Q4 2024
Reduced 0.01%
|
|
|
Persistent Asset Partners LTD
Hong Kong, K3 |
Feb 14, 2025 Q4 2024 |
145,760
shares
|
$599,073
0.23% of portfolio
|
Q4 2024
New holding
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
125,304
shares
|
$514,999
0.0% of portfolio
|
Q4 2024
Added 112.21%
|
|
|
Segall Bryant & Hamill, LLC
Chicago, IL |
Feb 11, 2025 Q4 2024 |
123,956
shares
|
$509,459
0.01% of portfolio
|
Q4 2024
Added 112.21%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Feb 14, 2025 Q4 2024 |
111,700
shares
|
$459,087
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Mariner, LLC
Overland Park, KS |
Feb 13, 2025 Q4 2024 |
98,289
shares
|
$403,967
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Superstring Capital Management LP
New York, NY |
Feb 14, 2025 Q4 2024 |
98,160
shares
|
$403,437
0.15% of portfolio
|
Q4 2024
Added 190.21%
|
|
|
Td Asset Management Inc
|
Feb 11, 2025 Q4 2024 |
89,400
shares
|
$367,434
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
70,093
shares
|
$288,082
0.0% of portfolio
|
Q3 2024
Added 309.23%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
66,472
shares
|
$273,199
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Walleye Capital LLC
Plymouth, MN |
Feb 13, 2025 Q4 2024 |
62,039
shares
|
$254,980
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Bailard, Inc.
|
Feb 05, 2025 Q4 2024 |
56,800
shares
|
$233,448
0.01% of portfolio
|
Q4 2024
New holding
|
|
|
Boothbay Fund Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
53,662
shares
|
$220,550
0.01% of portfolio
|
Q4 2024
Reduced 0.02%
|
|
|
Barclays PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
49,804
shares
|
$204,694
0.0% of portfolio
|
Q4 2024
Added 28.17%
|
|
|
Adar1 Capital Management, LLC
Austin, TX |
Feb 13, 2025 Q4 2024 |
48,125
shares
|
$197,793
0.02% of portfolio
|
Q4 2024
Reduced 70.56%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
39,034
shares
|
$160,429
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Feb 14, 2025 Q4 2024 |
38,900
shares
|
$159,879
0.0% of portfolio
|
Q4 2024
Reduced 21.45%
|
|
|
Squarepoint Ops LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
30,845
shares
|
$126,772
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
25,181
shares
|
$103,493
0.0% of portfolio
|
Q4 2024
Added 142.83%
|
|
|
Rhumbline Advisers
Boston, MA |
Apr 08, 2025 Q1 2025 |
24,782
shares
|
$101,854
0.0% of portfolio
|
Q1 2025
Reduced 22.16%
|
|
|
Citigroup Inc
|
Feb 12, 2025 Q4 2024 |
22,731
shares
|
$93,424
0.0% of portfolio
|
Q4 2024
Added 6.14%
|
|
|
Chicago Partners Investment Group LLC
|
Jan 23, 2025 Q4 2024 |
21,695
shares
|
$89,166
0.0% of portfolio
|
Q4 2024
Added 27.87%
|
|
|
Wells Fargo & Company
San Francisco, CA |
Feb 12, 2025 Q4 2024 |
17,062
shares
|
$70,124
0.0% of portfolio
|
Q4 2024
Added 28.79%
|
|
|
Mirae Asset Global Etfs Holdings Ltd.
Central, K3 |
Feb 14, 2025 Q4 2024 |
16,832
shares
|
$69,179
0.0% of portfolio
|
Q4 2024
Added 4.78%
|